About the Company
Filgotinib, sold under the brand name Jyseleca, is a medication used for the treatment of rheumatoid arthritis (RA). It was developed by the Belgian-Dutch biotech company Galapagos NV. The most common side effects include nausea (feeling sick), upper respiratory tract infection (nose and throat infection), urinary tract infection and dizziness. Filgotinib was approved for medical use in both the European Union and Japan in September 2020.
Exchange
NYSE
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $USPH News
USPH U.S. Physical Therapy, Inc.
U.S. Physical Therapy, Inc. operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company ...
U.S. Physical Therapy Announces Acquisitions
U.S. Physical Therapy, Inc. (“USPH” or the “Company”) (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial ...
U.S. Physical Therapy Announces Acquisition of a Nine-Clinic Physical Therapy And Hand Therapy Practice
U.S. Physical Therapy, Inc. ("USPH" or the “Company”) (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention ...
U.S. Physical Therapy, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call
How we use your information depends on the product and service that you use and your relationship with us. We may use it to ... and from the investor’s point of view. We also respect individual ...
U.S. Physical Therapy Announces Acquisition of a Nine-Clinic Physical Therapy And Hand Therapy Practice
U.S. Physical Therapy, Inc. ("USPH" or the “Company”) (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services ...
U.S. Physical Therapy, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call
HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced that ...
U.S. Physical Therapy
U.S. Physical Therapy, Inc. operates outpatient physical therapy clinics that provide preventative and post-operative care and treatment for orthopedic-related disorders, sports-related injuries ...
U.S. Physical Therapy, Inc.
U.S. Physical Therapy, Inc. operates outpatient physical therapy clinics, which provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries ...
U.S. Physical Therapy, Inc. Common Stock (USPH)
Analysts evaluate the stock’s expected performance in a given time period based on their research and their own opinions. Analyst ratings can be used in addition to other personal research work ...
U.S. Physical Therapy Announces Acquisitions
2024--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention ...
U.S. Physical Therapy, Inc. (USPH)
Note: if you don't see a key indicator sub score below it is because this company's data is not currently available for that area.
Loading the latest forecasts...